2021
Population characteristics, outcomes, and centerwide insights of the Zimbabwe national experience with the SIGN intramedullary nail (2013–2020)
Sibindi C, Mushambwe T, Mageza A, Socci A. Population characteristics, outcomes, and centerwide insights of the Zimbabwe national experience with the SIGN intramedullary nail (2013–2020). International Orthopaedics 2021, 46: 89-96. PMID: 34424393, DOI: 10.1007/s00264-021-05167-2.Peer-Reviewed Original ResearchConceptsSIGN Online Surgical DatabaseRoad traffic accidentsIntramedullary nailFracture fixationSIGN intramedullary nailMajority of patientsFemur fracture fixationVolume of patientsSIGN nailClinical outcomesOperative fixationRetrospective reviewSurgical databaseCommon causeSafe surgeryPopulation characteristicsPatientsSurgeryCommon procedureDifferent centersAverage timeNailOutcomesTraffic accidentsFixation
2020
Reliability of Radiographic Union Scoring in Humeral Shaft Fractures.
Schneble CA, Li DT, Kahan J, Brand J, Socci A, Haims A, Yoo BJ. Reliability of Radiographic Union Scoring in Humeral Shaft Fractures. Journal Of Orthopaedic Trauma 2020, 34: e437-e441. PMID: 32427814, DOI: 10.1097/bot.0000000000001811.Peer-Reviewed Original ResearchMeSH KeywordsAdultFracture HealingHumansHumeral FracturesHumerusReproducibility of ResultsRetrospective StudiesTreatment OutcomeConceptsHumeral shaft fracturesShaft fracturesRadiographic unionAmerican Level 1 Trauma CenterRetrospective medical record reviewLevel 1 trauma centerMedical record reviewInitial nonoperative managementDiaphyseal humerus fracturesHealing of boneIntraclass correlation coefficientClinic followAdult patientsNonoperative managementHumerus fracturesRecord reviewTrauma centerEmergency departmentInclusion criteriaLateral radiographsSystem scoreInterobserver reliabilityTime pointsPatientsFollow
2013
Community-Based Accompaniment and Psychosocial Health Outcomes in HIV-Infected Adults in Rwanda: A Prospective Study
Thomson D, Rich M, Kaigamba F, Socci A, Hakizamungu M, Bagiruwigize E, Binagwaho A, Franke M. Community-Based Accompaniment and Psychosocial Health Outcomes in HIV-Infected Adults in Rwanda: A Prospective Study. AIDS And Behavior 2013, 18: 368-380. PMID: 23443977, DOI: 10.1007/s10461-013-0431-2.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-HIV AgentsCD4 Lymphocyte CountCommunity Health ServicesCommunity Health WorkersDepressionDirectly Observed TherapyHIV InfectionsHumansMaleMedication AdherenceMiddle AgedPrevalenceProspective StudiesRegression AnalysisResidence CharacteristicsRural PopulationRwandaSocial SupportSocioeconomic FactorsTreatment OutcomeViral LoadConceptsCommunity-based accompanimentAntiretroviral treatmentPsychosocial health outcomesHealth outcomesCD4 cell countIngestion of medicationsPrevalence of depressionMental health qualityCommunity health workersMental health morbiditySocial supportFirst yearTreatment buddyProspective studyHealth morbidityHealth workersCell countNational protocolHIVPatientsHealth qualityImportant interventionCells/Greater improvementAdults
2012
Improved Retention Associated With Community-Based Accompaniment for Antiretroviral Therapy Delivery in Rural Rwanda
Franke M, Kaigamba F, Socci A, Hakizamungu M, Patel A, Bagiruwigize E, Niyigena P, Walker K, Epino H, Binagwaho A, Mukherjee J, Farmer P, Rich M. Improved Retention Associated With Community-Based Accompaniment for Antiretroviral Therapy Delivery in Rural Rwanda. Clinical Infectious Diseases 2012, 56: 1319-1326. PMID: 23249611, DOI: 10.1093/cid/cis1193.Peer-Reviewed Original ResearchConceptsAntiretroviral therapy (ART) deliveryViral load suppressionCommunity-based accompanimentClinic-based programsCD4 countViral loadHuman immunodeficiency virus (HIV) treatment programsProspective observational cohort studySecond multivariable analysisObservational cohort studyTherapy deliveryPhysical health qualityRural RwandaMultivariable regression modelsART initiationClinical characteristicsCohort studyMultivariable analysisBaseline differencesTreatment retentionTreatment programHealth qualityGood adherenceDeathFirst yearExcellent Clinical Outcomes and High Retention in Care Among Adults in a Community-Based HIV Treatment Program in Rural Rwanda
Rich M, Miller A, Niyigena P, Franke M, Niyonzima J, Socci A, Drobac P, Hakizamungu M, Mayfield A, Ruhayisha R, Epino H, Stulac S, Cancedda C, Karamaga A, Niyonzima S, Yarbrough C, Fleming J, Amoroso C, Mukherjee J, Murray M, Farmer P, Binagwaho A. Excellent Clinical Outcomes and High Retention in Care Among Adults in a Community-Based HIV Treatment Program in Rural Rwanda. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2012, 59: e35-e42. PMID: 22156912, DOI: 10.1097/qai.0b013e31824476c4.Peer-Reviewed Original ResearchConceptsCommunity-based antiretroviral therapyAntiretroviral therapyCommunity health workersHealth workersCD4 T-cell count increaseT-cell count increaseRetrospective medical record reviewCohort of patientsFree antiretroviral therapyHIV treatment programsMedical record reviewExcellent clinical outcomesRural health centersRural RwandaAdult patientsCommunity-based ART programMiddle-income countriesNutritional supportClinical outcomesOutcome benchmarksRecord reviewTuberculosis screeningExcellent outcomesHIV treatmentHIV programs
2006
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
Rich M, Socci A, Mitnick C, Nardell E, Becerra M, Bonilla C, Bayona J, Seung K, Furin J, Farmer P, Mukherjee J. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. The International Journal Of Tuberculosis And Lung Disease 2006, 10: 290-6. PMID: 16562709.Peer-Reviewed Original ResearchConceptsPrevious treatment exposureRetreatment regimensDrug susceptibility testingPatient populationDST patternsTreatment exposureGroup 1Likely effective drugsMDR-TB regimensSecond-line drugsDrug susceptibility patternsNational Tuberculosis ProgrammeDifferent patient populationsAnti-tuberculosis agentsIndividualized regimensMDR-TBTuberculosis ProgrammeEffective anti-tuberculosis agentsSusceptibility patternsDST resultsRegimensEffective drugsPatientsGroup 4Susceptibility testing
2004
Programmes and principles in treatment of multidrug-resistant tuberculosis
Mukherjee J, Rich M, Socci A, Joseph J, Virú F, Shin S, Furin J, Becerra M, Barry D, Kim J, Bayona J, Farmer P, Fawzi M, Seung K. Programmes and principles in treatment of multidrug-resistant tuberculosis. The Lancet 2004, 363: 474-481. PMID: 14962530, DOI: 10.1016/s0140-6736(04)15496-2.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisMDR-TB treatmentSecond-line anti-tuberculosis drugsSecond-line antituberculosis drugsRetrospective cohort studyAggressive treatment regimensGlobal tuberculosis controlAnti-tuberculosis drugsGreen Light CommitteeResource-poor settingsCohort studyObserved therapyTreatment regimensTreatment adherenceTuberculosis controlResource-poor areasAntituberculosis drugsLower potencyTreatmentTuberculosisDrugsGlobal FundRegimensDosingTherapy
2003
Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.
Mukherjee J, Joseph J, Rich M, Shin S, Furin J, Seung K, Sloutsky A, Socci A, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru F, Farmer P, Del Castillo H. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. The International Journal Of Tuberculosis And Lung Disease 2003, 7: 637-44. PMID: 12870684.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisPediatric MDR-TBMonths of therapySecond-line anti-tuberculosis drugsIntermediate outcomesFavorable clinical evolutionShort-course strategyAnti-tuberculosis drugsDOTS-PlusRespiratory insufficiencyRadiographic evidenceClinical evolutionObserved treatmentCase definitionChronic illnessClinical failureCommon causeEarly diagnosisTherapySuch childrenChildrenPatientsTreatmentTuberculosisProgrammatic considerations